I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Maria Bourkaltseva
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Elena Pleteneva
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Olga Shaburova
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Sergey Krylov
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Alexander Karaulov
Department of Clinical Immunology and Allergy, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, 119146 Moscow, Russia
Sergey Zhavoronok
Department of Infectious Diseases, Belarusian State Medical University, 220116 Minsk, Belarus
Oxana Svitich
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
Vitaly Zverev
I.I. Mechnikov Research Institute of Vaccines & Sera, 105064 Moscow, Russia
The paper covers the history of the discovery and description of phiKZ, the first known giant bacteriophage active on Pseudomonas aeruginosa. It also describes its unique features, especially the characteristic manner of DNA packing in the head around a cylinder-shaped structure (“inner body”), which probably governs an ordered and tight packaging of the phage genome. Important properties of phiKZ-like phages include a wide range of lytic activity and the blue opalescence of their negative colonies, and provide a background for the search and discovery of new P. aeruginosa giant phages. The importance of the phiKZ species and of other giant phage species in practical phage therapy is noted given their broad use in commercial phage preparations.